DocWire News Editors

DocwireNews

A new study suggests that the use of and &#8216;awake&#8217; management strategy of venoarterial extracorporeal membrane oxygenation (<a href="https://www.docwirenews.com/conference-coverage/hss-2019/complications-arise-va-ecmo/">VA-ECMO</a>) for cardiogenic shock is safe and effective.
&#8220;VA-ECMO is currently one of the first-line therapies for refractory cardiogenic shock, but its applicability is undermined by the high morbidity associated with its complications, especially those related to mechanical ventilation,&#8221; the authors wrote. &#8220;We aimed to assess the prognostic impact of keeping patients in refractory cardiogenic shock awake at cannulation and during the VA-ECMO run.&#8221;
The study was conducted as a propensity score-matched analysis of a data from 7-year database of patients given peripheral VA-ECMO support. The patient population included 213 patients, 91 of whom were awake and 140 who were non-awake. After adjusting for propensity-matching, the patients in the awake VA-ECMO group had lower rates of pneumonia, tracheostomy, renal replacement therapy, and less antibiotic and sedative consumption. The authors also reported a reduction in 60-day (20% vs. 41%, P=0.018) and 1-year mortality rates (31% vs. 54%, P=0.021) compared to the non-awake group.
&#8220;Although unmatched residual confounders might persist, this strategy was found to be associated with lower short- and long-term mortality,&#8221; the authors concluded. &#8220;Future research is now warranted to better define the clinical profile of patients who would most benefit from this ventilatory approach, as well as its impact on recovery after critical illness and post-traumatic stress-disorder symptoms.&#8221;
They added: &#8220;Our results underline that the impact of ‘awake’ ECMO management on outcome occurs early, because survival differences among groups remained steady thereafter. That observation is also consistent with previous studies showing stable mortality differences from the early stages of cardiogenic shock.&#8221;
The paper was published in the <a href="https://academic.oup.com/ehjacc/advance-article/doi/10.1093/ehjacc/zuab018/6211387?login=true">European Heart Journal: Acute Cardiovascular Care</a>.
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">
Finally published! New evidence supporting an <a href="https://twitter.com/hashtag/awakeECMO?src=hash&amp;ref_src=twsrc%5Etfw">#awakeECMO</a> management in <a href="https://twitter.com/hashtag/cardiogenicshock?src=hash&amp;ref_src=twsrc%5Etfw">#cardiogenicshock</a> Thanks to all who made it possible <a href="https://twitter.com/j_alvarezgarcia?ref_src=twsrc%5Etfw">@j_alvarezgarcia</a> <a href="https://twitter.com/m_rivaslasarte?ref_src=twsrc%5Etfw">@m_rivaslasarte</a> Awake venoarterial extracorporeal membrane oxygenation for refractory cardiogenic shock <a href="https://t.co/5UkNnbL3gc">https://t.co/5UkNnbL3gc</a>
&mdash; Santi Montero (@Santi4614) <a href="https://twitter.com/Santi4614/status/1379867289265307655?ref_src=twsrc%5Etfw">April 7, 2021</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">
Proud to be part of this pioneering project and prouder of your tireless interest in moving cardiac critical care forward <a href="https://twitter.com/Santi4614?ref_src=twsrc%5Etfw">@Santi4614</a> <a href="https://twitter.com/medicinauab?ref_src=twsrc%5Etfw">@medicinauab</a> <a href="https://twitter.com/hashtag/PhD?src=hash&amp;ref_src=twsrc%5Etfw">#PhD</a> <a href="https://twitter.com/hashtag/PhDlife?src=hash&amp;ref_src=twsrc%5Etfw">#PhDlife</a> <a href="https://twitter.com/hashtag/cardiotwitter?src=hash&amp;ref_src=twsrc%5Etfw">#cardiotwitter</a> <a href="https://twitter.com/hashtag/MedTwitter?src=hash&amp;ref_src=twsrc%5Etfw">#MedTwitter</a> <a href="https://twitter.com/hashtag/awakeECMO?src=hash&amp;ref_src=twsrc%5Etfw">#awakeECMO</a> <a href="https://twitter.com/hashtag/cardiogenicshock?src=hash&amp;ref_src=twsrc%5Etfw">#cardiogenicshock</a> <a href="https://twitter.com/hashtag/shock?src=hash&amp;ref_src=twsrc%5Etfw">#shock</a> <a href="https://t.co/mfSCMOmMhI">https://t.co/mfSCMOmMhI</a>
&mdash; Jesús Álvarez-García (@j_alvarezgarcia) <a href="https://twitter.com/j_alvarezgarcia/status/1379886901918896135?ref_src=twsrc%5Etfw">April 7, 2021</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>
&nbsp;

Maen Abdelrahim, MD, PhD

NAPOLI 3: UGT1A1*28 Polymorphism and Tolerability in Patients With mPDAC Treated With NALIRIFOX

Pancreatic Cancer

Cecilia Brown

2025 Cancer Statistics Report: Lung Cancer Remains Leading Cause of Cancer Mortality in US

Lung Cancer

Emily Menendez

Cytokine-Induced Killer Cells Boost RFS, CSS in HCC in Extended Follow-Up

Liver Cancer

Latest News

'Awake' ECMO Management Strategy in Cardiogenic Shock Safe, Effective

Cardiology

A new study suggests that the use of and 'awake' management strategy of venoarterial extracorporeal membrane oxygenation (VA-ECMO) for cardiogenic shock is safe and ...

About Us

Editorial Policy

Advertising

eNewsletters

Contribute

Contact Us

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

Mesothelioma

Non-Small Cell Lung Cancer

Small Cell Lung Cancer

Squamous Cell Lung Carcinoma

Lung Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

The Oncology Brothers

Rheumatology Rounds With Dr. Maheswaranathan

Healthcare Unfiltered

The Fellow on Call

Partners

Hurricanes & Health Care

Career Center

Expert Interviews

Subscribe